Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 205

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 205
---
 net loss per share                    | ​ | $                               | -4.05 | ​ | $ | -3.78 |

The accompanying notes are an integral part of these consolidated financial statements.

F-12

IRIS PARENT HOLDING CORP. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDER’S EQUITY FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

| ​                 
 ​                 
 ​                 | ​ 
 ​ |            ​ 
 Common Stock 
       Shares | ​ | ​      
 Amount | ​ | ​ | ​               
 Additional Paid 
 in Capital      |  ​ | ​ | ​                  
 Stock Subscription 
 Receivable         |   ​ | ​ | ​           
 Accumulated 
 Deficit     |    ​ | ​ | ​             
 Stockholder’s 
 Equity        |    ​ |
|:------------------|:--|-------------:|:--|:-------|:--|:--|:----------------|---:|:--|:-------------------|----:|:--|:------------|-----:|:--|:--------------|-----:|
| December 31, 2022 | ​ |          100 | ​ | $      | — | ​ | $               | 10 | ​ | $                  | -10 | ​ | $           |  -22 | ​ | $             |  -22 |
| Net loss          | ​ |            — | ​ | ​      | — | ​ | ​               |  — | ​ | ​                  |   — | ​ | ​           | -378 | ​ | ​             | -378 |
| December 31, 2023 | ​ |          100 | ​ | ​      | — | ​ | ​               | 10 | ​ | ​                  | -10 | ​ | ​           | -400 | ​ | ​             | -400 |
| Net loss          | ​ |            — | ​ | ​      | — | ​ | ​               |  — | ​ | ​                  |   — | ​ | ​           | -405 | ​ | ​             | -405 |
| December 31, 2024 | ​ |          100 | ​ | $      | — | ​ | $               | 10 | ​ | $                  | -10 | ​ | $           | -805 | ​ | $             | -805 |

The accompanying notes are an integral part of these consolidated financial statements.

F-13

IRIS PARENT HOLDING